IQVIA HOLDINGS INC. Payments for (Proceeds from) Investments
IQVIA HOLDINGS INC. (IQV) reported Payments for (Proceeds from) Investments of -$1.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2026-05-05
- IQVIA HOLDINGS INC. payments for (proceeds from) investments for the quarter ending 2026-03-31 was -$1.00M.
- IQVIA HOLDINGS INC. payments for (proceeds from) investments for the quarter ending 2025-12-31 was $22.00M, a 1000.00% increase year-over-year.
- IQVIA HOLDINGS INC. payments for (proceeds from) investments for the quarter ending 2025-09-30 was $0.00.
- IQVIA HOLDINGS INC. payments for (proceeds from) investments for the quarter ending 2025-06-30 was $0.00.
- IQVIA HOLDINGS INC. payments for (proceeds from) investments for fiscal 2025 was $20.00M, a 900.00% increase from fiscal 2024.
- IQVIA HOLDINGS INC. payments for (proceeds from) investments for fiscal 2024 was $2.00M, a 94.74% decline from fiscal 2023.
- IQVIA HOLDINGS INC. payments for (proceeds from) investments for fiscal 2023 was $38.00M.
- IQVIA HOLDINGS INC. payments for (proceeds from) investments for fiscal 2022 was $0.00.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 6 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 12 month | Payments for (Proceeds from) Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | -$1.00M 10-Q · filed 2026-05-05 | $21.00M derived: sum of 2 quarters · filed 2026-05-05 | $21.00M derived: sum of 3 quarters · filed 2026-05-05 | $21.00M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $22.00M derived: sum of 2 quarters · filed 2026-02-17 | $22.00M derived: sum of 3 quarters · filed 2026-02-17 | $20.00M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $0.00 derived: sum of 2 quarters · filed 2025-10-28 | -$2.00M 10-Q · filed 2025-10-28 | $0.00 derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | -$2.00M 10-Q · filed 2025-07-22 | $0.00 derived: sum of 3 quarters · filed 2026-05-05 | $0.00 derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-03-31 | -$2.00M 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $0.00 derived: sum of 3 quarters · filed 2026-05-05 | -$1.00M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.00M derived: sum of 2 quarters · filed 2026-02-17 | $1.00M derived: sum of 3 quarters · filed 2026-02-17 | $2.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$1.00M derived: sum of 2 quarters · filed 2025-10-28 | $0.00 10-Q · filed 2025-10-28 | ||
| 2024-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $0.00 10-Q · filed 2025-07-22 | |||
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-06 | ||||
| 2023-12-31 | $38.00M 10-K · filed 2026-02-17 | ||||
| 2022-12-31 | $0.00 10-K · filed 2025-02-13 | ||||
| 2021-12-31 | -$5.00M 10-K · filed 2024-02-15 | ||||
| 2020-12-31 | $2.00M 10-K · filed 2023-02-15 | ||||
| 2019-12-31 | $22.00M 10-K · filed 2022-02-16 | ||||
| 2018-12-31 | $23.00M 10-K · filed 2021-02-12 | ||||
| 2017-12-31 | -$2.00M 10-K · filed 2018-02-16 | ||||
| 2016-12-31 | -$41.00M 10-K · filed 2019-02-19 | $40.00M 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |